“…GAL shows a widespread distribution by the mammalian peripheral and central nervous systems, including the feeding–regulating hypothalamus (e.g., PVH, Arc and dorsomedial nuclei). In addition to feeding, GAL and related peptides are involved in cardiovascular, respiratory, gastrointestinal and neuroendocrine mechanisms, memory, cognition, osmotic/metabolic homeostasis, reproduction, neural growth, arousal, sleep, injury response as well as in depression, anxiety, epilepsy, diabetes mellitus, inflammatory bowel disease, pain, stroke, cancer, alcohol intake, multiple sclerosis, Alzheimer disease (where upregulation of GAL occurs) and affective behaviour [ 2 , 26 , 31 ]. It has been reported that modifications in pain threshold (antinociceptive and nociceptive) caused by obesity are modulated by GAL [ 33 ].…”